Jing Su

3.9k total citations
122 papers, 2.4k citations indexed

About

Jing Su is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jing Su has authored 122 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 35 papers in Oncology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jing Su's work include Brain Metastases and Treatment (20 papers), Lung Cancer Research Studies (16 papers) and Glioma Diagnosis and Treatment (12 papers). Jing Su is often cited by papers focused on Brain Metastases and Treatment (20 papers), Lung Cancer Research Studies (16 papers) and Glioma Diagnosis and Treatment (12 papers). Jing Su collaborates with scholars based in United States, China and New Zealand. Jing Su's co-authors include Qianqian Song, Xiaobo Zhou, Wei Zhang, Sibo Jiang, Jianjun Chen, Yao Liu, Xiaoxun Li, Ling Li, Lance D. Miller and Jimmy Ruiz and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

Jing Su

109 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Su United States 27 1.1k 673 516 368 261 122 2.4k
Karthik Devarajan United States 28 1.6k 1.4× 916 1.4× 492 1.0× 512 1.4× 211 0.8× 114 3.1k
Ting Niu China 27 1.3k 1.2× 800 1.2× 225 0.4× 290 0.8× 607 2.3× 230 3.0k
Marco Prunotto Switzerland 26 1.5k 1.4× 346 0.5× 619 1.2× 209 0.6× 418 1.6× 80 3.8k
Nikolaos Kavantzas Greece 30 1.0k 0.9× 605 0.9× 444 0.9× 371 1.0× 243 0.9× 183 2.9k
Jianxin Xue China 29 796 0.7× 815 1.2× 787 1.5× 427 1.2× 347 1.3× 143 2.3k
Xingchen Peng China 30 855 0.8× 656 1.0× 360 0.7× 384 1.0× 148 0.6× 168 2.6k
Guoping Wang China 24 977 0.9× 419 0.6× 280 0.5× 361 1.0× 207 0.8× 87 1.9k
Xiuwen Wang China 33 1.6k 1.4× 1.2k 1.8× 674 1.3× 585 1.6× 459 1.8× 174 3.3k
Heng Zhou China 26 833 0.8× 650 1.0× 281 0.5× 235 0.6× 480 1.8× 131 2.6k

Countries citing papers authored by Jing Su

Since Specialization
Citations

This map shows the geographic impact of Jing Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Su more than expected).

Fields of papers citing papers by Jing Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Su. The network helps show where Jing Su may publish in the future.

Co-authorship network of co-authors of Jing Su

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Su. A scholar is included among the top collaborators of Jing Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Su. Jing Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zapartas, Emmanouil, Ori D. Fox, Jing Su, et al.. (2025). The demographics of binary companions to stripped-envelope supernovae: confronting population synthesis models with observations. Monthly Notices of the Royal Astronomical Society. 546(2). 1 indexed citations
2.
Wang, Yanfei, Yi Guo, Aik Choon Tan, et al.. (2025). A real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors. npj Precision Oncology. 9(1). 346–346.
3.
Zhang, Jia, Dan Zhu, Wenquan Ma, et al.. (2024). The diagnostic value of peripheral blood lymphocyte testing in children with infectious mononucleosis. BMC Pediatrics. 24(1). 746–746. 1 indexed citations
4.
D’Agostino, Ralph B., Jimmy Ruiz, Lance D. Miller, et al.. (2024). Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer. Cancer Research. 84(23). 4002–4016. 4 indexed citations
5.
Yang, Zhihong, Hui Gao, Jing Ma, et al.. (2024). Unique urine and serum metabolomic signature in patients with excessive alcohol use: An exploratory study. Alcohol Clinical and Experimental Research. 48(8). 1519–1528. 1 indexed citations
6.
Liu, Xiang, et al.. (2024). TrialView: An AI-powered Visual Analytics System for Temporal Event Data in Clinical Trials. Proceedings of the ... Annual Hawaii International Conference on System Sciences.
7.
Tang, Ziyang, et al.. (2024). xSiGra: explainable model for single-cell spatial data elucidation. Briefings in Bioinformatics. 25(5). 6 indexed citations
8.
Tang, Ziyang, Pengyue Zhang, Michael T. Eadon, et al.. (2024). TrajVis: a visual clinical decision support system to translate artificial intelligence trajectory models in the precision management of chronic kidney disease. Journal of the American Medical Informatics Association. 31(11). 2474–2485. 5 indexed citations
9.
Wang, Yuezhu, Ralph B. D’Agostino, Jimmy Ruiz, et al.. (2024). IASLC grading system predicts distant metastases for resected lung adenocarcinoma. Journal of Clinical Pathology. 78(6). 409–415. 1 indexed citations
10.
Kettler, Carla, et al.. (2024). ARDaC Common Data Model Facilitates Data Dissemination and Enables Data Commons for Modern Clinical Studies. Studies in health technology and informatics. 310. 3–7.
12.
Wang, Yuezhu, Ralph B. D’Agostino, Jimmy Ruiz, et al.. (2023). c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil Activities. Cancers. 15(9). 2626–2626. 13 indexed citations
13.
Eadon, Michael T., Judith Maddatu, Sharon M. Moe, et al.. (2021). Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study. Kidney360. 3(2). 307–316. 13 indexed citations
14.
15.
Song, Qianqian & Jing Su. (2020). DSTG: deconvoluting spatial transcriptomics data through graph-based artificial intelligence. Briefings in Bioinformatics. 22(5). 143 indexed citations
16.
LeCompte, M.C., Ryan T. Hughes, Michael Farris, et al.. (2020). Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery. Journal of Neuro-Oncology. 146(2). 285–292. 8 indexed citations
17.
Wang, Hao, Xuming Sun, Sarfaraz Ahmad, et al.. (2019). Estrogen modulates the differential expression of cardiac myocyte chymase isoforms and diastolic function. Molecular and Cellular Biochemistry. 456(1-2). 85–93. 7 indexed citations
18.
Thomas, Alexandra, Eric D. Routh, Ashok Pullikuth, et al.. (2018). Tumor mutational burden is a determinant of immune-mediated survival in breast cancer. OncoImmunology. 7(10). e1490854–e1490854. 209 indexed citations
19.
Chen, Wei, et al.. (2016). Relational Network for Knowledge Discovery through Heterogeneous Biomedical and Clinical Features. Scientific Reports. 6(1). 29915–29915. 8 indexed citations
20.
Liu, Chenglin, Jing Su, Fei Yang, et al.. (2015). Compound signature detection on LINCS L1000 big data. Molecular BioSystems. 11(3). 714–722. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026